Not rated

Is HAMA always a bad thing?

Not all patients develop HAMA. The development of HAMA can be delayed by several months by administering certain...
Revision #1 Posted by Mark Dungan on 11 Jul 2009
Not rated

What is 3F8?

3F8 is a mouse derived monoclonal antibody developed by Dr. Cheung at Case Western Reserve University in the 1980’s...
Revision #3 Posted by Mark Dungan on 11 Jul 2009
Not rated

What are the benefits of the ch14.18 antibody?

The benefit of the ch14.18 antibody is that it has been shown in laboratory studies to be just as effective at...
Revision #1 Posted by Mark Dungan on 11 Jul 2009
Not rated

How has the antibody been used?

The ch14.18 antibody has been used in clinical trials both as a single agent and in combination with augmenting...
Revision #1 Posted by Mark Dungan on 11 Jul 2009
Not rated

What are the differences between the ch14.18 antibody and 3F8?

Although the ch14.18 and 3F8 antibodies both share the same target on neuroblastoma cells, the GD2 antigen, there...
Revision #1 Posted by Mark Dungan on 11 Jul 2009
1 2 Next >